by Bill Malloy | Sep 27, 2022 | Uncategorized
Two recent cancer studies have shown that some cancer patients may be able to safely skip radiation or chemotherapy following surgery. The first study used a blood test to evaluate which colon cancer patients could safely forgo post-surgery treatment, while the other...
by Bill Malloy | Sep 13, 2022 | Uncategorized
Statistically, men with cancer have worse prognoses and outcomes compared to women. This discrepancy has been the subject of extensive study over the past few decades, but the oncology community is still working toward understanding the difference. However, a study...
by Bill Malloy | Sep 12, 2022 | Uncategorized
In a recent clinical trial, an experimental cancer-killing virus was tested on a human patient for the first time. Known by the brand name Vaxinia (CF33-hNIS), the tested drug is a type of oncolytic virus therapy. This genetically modified virus is designed to...
by Bill Malloy | Sep 1, 2022 | Uncategorized
A drug commonly used to treat HIV patients may be a viable treatment for metastatic cancers, according to findings from a trial recently published in the journal Cancer Discovery. While the study focused on patients with fourth-line metastatic colorectal cancer, the...
